| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |